Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July 1st, 1996 to July 18th, 1996
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5395 (In Vivo Mammalian Cytogenetics Tests: Erythrocyte Micronucleus Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 1983
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- 3‐benzoyl‐2,6‐bis({[3‐(‐lambda5‐diazynylidene)‐4‐oxo‐3,4‐dihydronaphthalen‐1‐yl]sulfonyl}oxy)phenyl 3‐(‐lambda5‐diazynylidene)‐4‐oxo‐3,4‐dihydronaphthalene‐1‐sulfonate
- Cas Number:
- 11562-47-8
- Molecular formula:
- not applicable as UVCB
- IUPAC Name:
- 3‐benzoyl‐2,6‐bis({[3‐(‐lambda5‐diazynylidene)‐4‐oxo‐3,4‐dihydronaphthalen‐1‐yl]sulfonyl}oxy)phenyl 3‐(‐lambda5‐diazynylidene)‐4‐oxo‐3,4‐dihydronaphthalene‐1‐sulfonate
- Test material form:
- solid
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- other: SHOE:NMRI
- Details on species / strain selection:
- The mouse is the recommended test species for this assay.
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Tierzucht Schönwalde GmbH i.G., Schönwalde, Germany
- Age at study initiation: appr. 8 weeks
- Weight at study initiation: males mean: 36.8 g, females mean: 29.8 g
- Housing: five animals per cage
- Diet: ad libitum rat/mice diet ssniff (ssniff GmbH, Soest, Germany)
- Water: tap water ad libitum
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+/- 3
- Humidity (%): 50+/-20
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle/solvent used: sesame oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
On the day of the experiment, the test item was suspended in sesame oil. A magnetic stirrer was used to keep the preparation homogenous until administration. - Duration of treatment / exposure:
- one treatment
- Frequency of treatment:
- one oral gavage treatment
- Post exposure period:
- Animals were killed 12, 24 or 48 h after dosing.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 2 000 mg/kg bw/day (nominal)
- Remarks:
- killing times: 12, 24 or 48 h, 5 males and 5 females each
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Remarks:
- killing times: 12, 24 or 48 h, 5 males and 5 females each
- No. of animals per sex per dose:
- 5 per killing time
- Control animals:
- yes
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Route of administration: oral (gavage)
- Doses / concentrations: 50 mg/kg bw
Examinations
- Tissues and cell types examined:
- erythrocytes
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
prelinimary toxicity study
DETAILS OF SLIDE PREPARATION:
A suspension of bone marow (taken from the femorae) and fetal bovine serum was formed and centrifuged for 5 minutes at app. 1200 rpm. The supernatant was discarded. The sediment was smeared on a clean slide. Staining was performed with Giemsa solution.
METHOD OF ANALYSIS:
1000 polychromatic erythrocytes were counted for each animal. The number of cells with micronuclei was recorded. - Evaluation criteria:
- A substance is considered positive if there is a significant increase in the numbe rof micronucleated polychromatic erythrocytes for at least one of the time points compared with the concurent negative control group.
- Statistics:
- Wilcoxon-test (one-sided)
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- No mortality and no clinical signs of toxicity were observed. No macroscopic findings were recorded at dissection.
Any other information on results incl. tables
Please refer to the attached background material.
Applicant's summary and conclusion
- Conclusions:
- The test item was not clastogenic in vivo under the conditions of the present study.
- Executive summary:
The test substance was tested in an in vivo micronucleus test according to OECD Guideline 474. The test item was suspended in sesame oil and administered once via gavage at doses of 0 and 2000 mg/kg bw to male and female NMRI mice. The animals were killed either after 12, 24 or 48 h (5/sex/killing time). Endoxan (cyclophosphamide) was used as positive control at a dose of 50 mg/kg bw. The number of polychromatic and normochromatic erythrocytes containing micronuclei was not increased. The ratio of polychromatic/normochromatic erythrocytes in both male and female animals remained unaffected by the treatment with the test item and was statistically not different from the control values. The positive control induced a marked statistically significant increase in the number of polychromatic cells with micronuclei. The ratio of polychromatic erythrocytes to normocytes was not changes to a significant extent. Under the conditions of the study, th test item is not mutagenic in this test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.